mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0008 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.002 |